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Essentially the same general radiobiological considerations apply to 
kilovoltage as to megavoltage x rays i.e. cell killing is adequately 
described by the linear-quadratic model, and for (most) tumour 
types we expect a higher α/β than for normal tissues thus making 
fractionation theoretically advantageous. However, given the ex-
tremely rapid fall-off of dose with depth, and the fact that today only 
superficial tumours are treated with kilovoltage beams, the dose to 
any underlying normal tissues will inevitably be very low and may 
therefore pose a negligible complication risk. This enables large 
fractions to be used. 
Megavoltage therapy was already well established when computer 
planning systems first came on the scene in the 1970s. Naturally all 
the effort went into developing algorithms for computing dose in 
patients from such beams and consequently no treatment planning 
systems model kilovoltage beams. The very large amount of (photon) 
scatter, which gives rise to a build-up of dose at small depths, would 
pose quite a challenge for algorithm developers, though secondary 
electron transport can be ignored as the low initial electron ener-
gies result in largely sub-millimetre ranges in tissue. We have created 
a simple 250 kV x-ray plan for a lung tumour using the GEANT Monte-
Carlo code in order to compare the DVHs to those derived from a 
megavoltage plan. For one particular NSCLC patient, treated with 6 
MV x rays, this comparion has yielded 0% TCP for the kV plan for the 
same 9.5% lung pneumonitis NTCP as for the MV plan. Increasing the 
NTCP to 15% for both plans (i.e. by winding up the MUs) has yielded 
TCPs of 94.6% for the MV plan against 1.9% for the kV plan. However, 
this was for a realtively large tumour.   
It can be noted that kilovoltage therapy is undergoing a renais-
sance through 50 kV 'Papillon' contact therapy for rectal tumours.     
   
 SYMPOSIUM: IMPROVING ACCURACY IN IGRT TREAT-
MENT DELIVERY  
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Purpose: Accuracy in patients positioning with novel irradiation 
techniques, which allow tight conformation of dose distribution, is of 
great interest in image guided radiotherapy (IGRT) era.  
Material and methods: Several studies have examined the relevance 
and the magnitude of rotational set up errors, using portal image 
registration, serial CT scans or recently employing kilovoltage cone-
beam CT (CBCT). They demonstrated that in prostate, head & neck 
and thoracic cancer, rotational errors are small in magnitude but 
statistically significant and that their magnitude is not correlated with 
the magnitude of the translational set up errors. Morevover several 
authors demonstrated that online correction of rotation can improve 
target coverage because rotational shift could have an impact on dose 
distribution, varying according to treatment site and to radiation 
techniques. Therefore an approach to improving accuracy of patient 
positioning is to develop devices that permit couch movement with 
6°of freedom (6DOF). In our centre the ProturaTM Robotic Patient 
Positioning System (CIVCO Medical Solution) was installed onto a 
Linear accelerator (Varian Medical System). We started a study to 
evaluate therelevance of rotational shift in IGRT and to validate the 
added value of  6DOF robotic couch to  improve setup accuracy with 
the Cone Beam CTscanner (CBCT). The radiation therapist and techni-
cians were instructed to use the system and, through daily use, de-
termined the best application of the system. 
Results: Guckenberger et al. found a rotational error >2° in 3.7% of 
pelvic tumors, 26.4% of thoracic tumors and 12,4% of head and neck 
tumors; the corresponding maximal rotational errors were 5° , 8° and 
6°. Kaiser et al. observed in 96.6% of prostate and head and neck 
cancer a rotational correction <4°, with no difference between week 
1 and 4 of treatment; a smaller pitch variation but a larger yaw 
variation were recorded in head and neck. Concerning dosimetric 
results,  Guckenberger et al. observed a decreased target coverage 
and an highly increased dose to the organat at risk (OAR) when elon-
gated target volume and sharp dose gradients were adjacent to OAR. 
Lang et al. observed a reduction of target coverage for pitch of 3° 
with no differences between dorsal o ventral direction. In our centre 
from October to December 2012, 5 prostate and 3 H&N patients were 
enrolled. The magnitude of roll variation was  greater in both groups 
(mean (±SD) of -0.5±1.2° in prostate and a maximal value of 3.8° and 
a mean (±SD) of 1.3±1,2 ° in H&N with a maximal value of 3.4°). The 
pitch variations were greater for patients treated to the pelvis (means 
(±SD) of -0.4±1.1° vs -0.1±0.8° with a maximal value of 2.8° vs 1.9°), 
while the mean (±SD) interfractional yaw was 0.1±0.7° in prostate and 
0.0±0.6° in H&N patients. No correlation was observed between the 
magnitude of translational and rotational shift in either group. The 
online correction using CBCT studies added less than one minute to 
the treatment time when compared to IGRT without robotic 6DOF 
couch. 
Conclusions: These data confirm the relevance of rotational shift and 
the feasibility of using a robotic 6 DOFcorrection table in routine 
radiotherapy. In our centre correlation between volumetric and 
geometrical shift data and evaluation of its dosimetrical impact on 
adaptive dose is ongoing.  
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This presentation discusses an ongoing project lead by members of the 
ESTRO RTT Committee on the Development of guidelines for set up 
and verification requirements in head and neck radiotherapy.  This is 
the first set of ESTRO guideline to be developed by RTTs. 
The presentation will give the background as to why ESTRO develops 
guidelines for its members, the rationale for the selection of this topic 
and the progress to date. 
The methodology for the project includes an extended literature 
review, the development of an online questionnaire and its translation 
and distribution to RTTs throughout Europe as well as case reports 
from selected clinical departments across Europe. 
The results of the extended literature review will be presented, along 
with the preliminary results of the questionnaire and the focus of the 
case reports will be discussed.  
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Irradiation of bladder cancer is challenging since the variable and 
deformable bladder and bowel filling makes the target highly mobile. 
Traditionally, large target margins (up to several cm) are applied with 
the high dose area comprising the full range of bladder filling. Innova-
tions were enabled by the introduction of Cone Beam CT (CBCT) 
during the last decade.  
A challenge for image guided radiotherapy is that the tumor on the 
bladder wall is difficult to delineate on planning CT and not visible at 
all on CBCT. Several procedures are developed to demarcate the 
tumor, using cystoscopy. For instance, the contrast liquid lipiodol is 
successfully injected in the bladder wall to locate the tumor using a 
flexible scope. Lipiodol markers are well visible on CT for guiding 
target delineation. Moreover, markers are also visible on CBCT during 
the whole treatment course enabling daily target localization. 
The visibility of the target on CBCT in combination with a rather well 
visible bladder wall enabled application of adaptive radiotherapy 
(ART) procedures. Currently reported ART procedures are variations 
on the following scheme: 
 Acquisition of planning CTs with varying bladder filling (typically 
a full and empty bladder). 
 Creation of a number of 'additional bladders', with interpolated 
(or also extrapolated) volumes. 
 Design of plans-of-the-day (PDs) for each bladder volume. 
 Treatment with daily CBCT acquisition. 
 Patient repositioning, based on bony anatomy or tumor markers. 
 Based on the amount of bladder filling the correct PD is selected 
and delivered. 
This approach has shown to enable a significant reduction of the 
target margins and sparing of organs-at-risk like the small bowel and 
healthy part of the bladder. 
One of the challenges for clinical introduction of ART is the PD selec-
tion. This selection is based on the bladder volume. It is possible to 
automate the bladder delineation on CBCT. An approach with a 
'restricted bladder shape' has been investigated, fitting the shape on 
the grey value gradient of the CBCT image. As final check, the auto-
matically obtained bladder shape can be corrected manually. This 
approach turned out to be effective in selecting the correct PD and 
corresponds in 81% with the manually chosen PD.  
To report the actually given dose to each daily deformed target and 
bladder shape, the daily dose must be accumulated. It requires an 
anatomically correct deformable registration, defining the corres-
